Results 191 to 200 of about 37,663 (284)
Reply to: On the "2-minute rule". [PDF]
Debaty G, Menant E, Jouven X.
europepmc +1 more source
Predicting return of spontaneous circulation in out-of-hospital cardiac arrest resuscitated in the emergency department: a single center retrospective study. [PDF]
Zuo S, Wei G, Li H.
europepmc +1 more source
ABSTRACT Background Frailty is highly prevalent among recently hospitalized adults and is associated with functional decline, dependency, and increased mortality. Although conventional physiotherapy is routinely applied in transitional care settings, its effectiveness may be limited in frail individuals with low tolerance to exercise.
André Luis Pinheiro Borges +7 more
wiley +1 more source
Enhancing Patient Safety in Refractory Ventricular Fibrillation: A Systematic Review of Double Sequential and Vector Change Defibrillation Barriers. [PDF]
Alexandrou K +2 more
europepmc +1 more source
ABSTRACT Background Perioperative glucose monitoring traditionally relies on intermittent point‐of‐care (POC) testing, whereas continuous glucose monitoring (CGM) enables real‐time glucose assessment with automated alerts for dysglycaemia. CGM remains understudied in hospitalised surgical patients with diabetes.
Casper Pedersen +4 more
wiley +1 more source
ABSTRACT Introduction Out‐of‐hospital cardiac arrest (OHCA) is associated with high mortality and substantial long‐term neurological sequelae among survivors. During postresuscitation intensive care after return of spontaneous circulation (ROSC), myocardial dysfunction, vasoplegia, and mixed shock states are often observed.
Johannes Grand +11 more
wiley +1 more source
Transient R-wave amplitude attenuation owing to air entrapment during extravascular implantable cardioverter-defibrillator implantation: Delayed reassessment as a potential bail-out strategy. [PDF]
Yanase T +5 more
europepmc +1 more source
Background and Purpose Novel heart failure (HF) pharmacotherapies, including angiotensin receptor‐neprilysin inhibitor (ARNI) and sodium‐glucose cotransporter 2 inhibitors (SGLT2is), may confer cardiovascular benefits by attenuating myocardial fibrosis. However, direct evidence from human failing myocardial samples is limited.
Dávid Nagy +10 more
wiley +1 more source

